Erratum: Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO (Journal of Cerebral Blood Flow & Metabolism (2013) 33 (37-47) DOI: 10.1038/jcbfm.2012.128);Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 1, 2013, Pages 37-47

  Stubbe, Tobias ^a   Ebner, Friederike ^a   Richter, Daniel ^a   Randolf Engel, Odilo ^a   Klehmet, Juliane ^a   Royl, Georg ^a   Meisel, Andreas ^a   Nitsch, Robert ^b   Meisel, Christian ^a   Brandt, Christine ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

focal ischemia; immunology; leukocytes; macrophages; microglia; neuroprotection; T cells

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BRAIN ISCHEMIA; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 84871928577     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.149     Document Type: Erratum

References (39)

1. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol2007; 184: 53-68. (Pubitemid 46365991)
2. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe C-U, Siler DA et al.Temporal and spatial dynamics of cerebral immune cell accumulation in stroke.Stroke 2009; 40: 1849-1857.
3. Kleinschnitz C, Schwab N, Kraft P, Hagedorn I, Dreykluft A, Schwarz T et al. Earlydetrimental T-cell effects in experimental cerebral ischemia are neither related toadaptive immunity nor thrombus formation. Blood 2010; 115: 3835-3842.
4. Prass K, Meisel C, Hö flich C, Braun J, Halle E, Wolf T et al. Stroke-induced immunodeficiencypromotes spontaneous bacterial infections and is mediated bysympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.J Exp Med 2003; 198: 725-736. (Pubitemid 37087772)
5. Neumann-Haefelin T, Kastrup A, de Crespigny A, Yenari MA, Ringer T, Sun GH et al.Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury,blood-brain barrier damage, and edema formation. Stroke 2000; 31: 1965-1973. (Pubitemid 30620481)
6. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injuryinducedimmune deficiency syndrome. Nat Rev Neurosci 2005; 6: 775-786. (Pubitemid 41679240)
7. Becker KJ, Kindrick DL, Lester MP, Shea C, Ye Z-C. Sensitization to brain antigensafter stroke is augmented by lipopolysaccharide. J Cereb Blood Flow Metab 2005;25: 1634-1644. (Pubitemid 41683174)
8. Gee JM, Kalil A, Shea C, Becker KJ. Lymphocytes: potential mediators of postischemicinjury and neuroprotection. Stroke 2007; 38: 783-788. (Pubitemid 46188255)
9. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. Regulatory T cells:how do they suppress immune responses? Int Immunol 2009; 21: 1105-1111.
10. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S et al. RegulatoryT cells are key cerebroprotective immunomodulators in acute experimentalstroke. Nat Med 2009; 15: 192-199.
11. Gee JM, Kalil A, Thullbery M, Becker KJ. Induction of immunologic tolerance tomyelin basic protein prevents central nervous system autoimmunity andimproves outcome after stroke. Stroke 2008; 39: 1575-1582.
12. Gee JM, Zierath D, Hadwin J, Savos A, Kalil A, Thullbery M et al. Long termimmunologic consequences of experimental stroke and mucosal tolerance.Exp Transl Stroke Med 2009; 1: 3-3.
13. Wang Y, Kissenpfennig A, Mingueneau M, Richelme S, Perrin P, Chevrier S et al.Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independentlyof TCR-MHC engagement and is insensitive to the action of Foxp3\+ regulatoryT cells. J Immunol 2008; 180: 1565-1575.
14. Schmerbach K, Schefe JH, Krikov M, Mü ller S, Villringer A, Kintscher U et al.Comparison between single and combined treatment with candesartan andpioglitazone following transient focal ischemia in rat brain. Brain Res 2008; 1208:225-233.
15. Gerriets T, Stolz E, Walberer M, Muller C, Kluge A, Bachmann A et al. Noninvasivequantification of brain edema and the space-occupying effect in rat strokemodels using magnetic resonance imaging. Stroke 2004; 35: 566-571. (Pubitemid 38174451)
16. Hetze S, Römer C, Teufelhart C, Meisel A, Engel O. Gait analysis as a method forassessing neurological outcome in a mouse model of stroke. J Neurosci Methods2012; 206: 7-14.
17. Hamers FPT, Lankhorst AJ, van Laar TJ, Veldhuis WB, Gispen WH. Automatedquantitative gait analysis during overground locomotion in the rat: its applicationto spinal cord contusion and transection injuries. J Neurotrauma 2001; 18:187-201. (Pubitemid 32173426)
18. Campanella M, Sciorati C, Tarozzo G, Beltramo M. Flow cytometric analysis ofinflammatory cells in ischemic rat brain. Stroke 2002; 33: 586-592. (Pubitemid 34123411)
19. Felger JC, Abe T, Kaunzner UW, Gottfried-Blackmore A, Gal-Toth J, McEwen BSet al. Brain dendritic cells in ischemic stroke: Time course, activation state, andorigin. Brain Behav Immun 2010; 24: 724-737.
20. Babcock AA, Kuziel WA, Rivest S, Owens T. Chemokine expression by glialcells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 2003; 23:7922-7930. (Pubitemid 37052361)
21. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown.J Cell Phys 2000; 182: 311-322. (Pubitemid 30054364)
22. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 6: 1142-1151. (Pubitemid 41541792)
23. Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of naturalFoxp3\+ CD25\+ CD4\+ regulatory T cells by interleukin (IL)-2 and induction ofautoimmune disease by IL-2 neutralization. J Exp Med 2005; 201: 723-735. (Pubitemid 40395118)
24. Jander S, Kraemer M, Schroeter M, Witte OW, Stoll G. Lymphocytic infiltration andexpression of intercellular adhesion molecule-1 in photochemically inducedischemia of the rat cortex. J Cereb Blood Flow Metab 1995; 15: 42-51.
25. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von BoehmerH. Inducing and expanding regulatory T cell populations by foreign antigen.Nat Immunol 2005; 6: 1219-1227. (Pubitemid 43045633)
26. Liang S, Alard P, Zhao Y, Parnell S, Clark SL, Kosiewicz MM. Conversion of CD4\+CD25-cells into CD4\+ CD25\+ regulatory T cells in vivo requires B7 costimulation,but not the thymus. J Exp Med 2005; 201: 127-137.
27. Guo F, Iclozan C, Suh W-K, Anasetti C, Yu X-Z. CD28 controls differentiation ofregulatory T cells from naive CD4 T cells. J Immunol 2008; 181: 2285-2291.
28. Aloisi F, Ria F, Adorini L. Regulation of T-cell responses by CNS antigen-presentingcells: different roles for microglia and astrocytes. Immunol Today 2000; 21:;141-147.
29. Almolda B, González B, Castellano B. Activated microglial cells acquire animmature dendritic cell phenotype and may terminate the immune response inan acute model of EAE. J Neuroimmunol 2010; 223: 39-54.
30. Chen X, Hamano R, Subleski JJ, Hurwitz AA, Howard OMZ, Oppenheim JJ.Expression of costimulatory TNFR2 induces resistance of CD4\+FoxP3- conventionalT cells to suppression by CD4\+FoxP3\+ regulatory T cells. J Immunol 2010;185: 174-182.
31. Soares A, Govender L, Hughes J, Mavakla W, de Kock M, Barnard C et al. Novelapplication of Ki67 to quantify antigen-specific in vitro lymphoproliferation.J Immunol Methods 2010; 362: 43-50.
32. Lv K, Xu W, Wang C, Niki T, Hirashima M, Xiong S. Galectin-9 administrationameliorates CVB3 induced myocarditis by promoting the proliferation of regulatoryT cells and alternatively activated Th2 cells. Clin Immunol 2011; 140:92-101.
33. Shin H-J, Baker J, Leveson-Gower DB, Smith AT, Sega EI, Negrin RS. Rapamycin andIL-2 reduce lethal acute graft-versus-host disease associated with increasedexpansion of donor type CD4\+CD25\+Foxp3\+ regulatory T cells. Blood 2011;118: 2342-2350.
34. Lee WT, Pasos G, Cecchini L, Mittler JN. Continued antigen stimulation is notrequired during CD4\+ T cell clonal expansion. J Immunol 2002; 168: 1682-1689. (Pubitemid 34135764)
35. Curotto de Lafaille MA, Lino AC, Kutchukhidze N, Lafaille JJ. CD25-T cells generateCD25\+Foxp3\+ regulatory T Cells by peripheral expansion. J Immunol 2004; 173:7259-7268. (Pubitemid 39628162)
36. Couper KN, Lanthier PA, Perona-Wright G, Kummer LW, Chen W, Smiley ST et al.Anti-CD25 antibody-mediated depletion of effector T cell populations enhancessusceptibility of mice to acute but not chronic Toxoplasma gondii infection.J Immunol 2009; 182: 3985-3994.
37. Ren X, Akiyoshi K, Vandenbark AA, Hurn PD, Offner H. CD4\+FoxP3\+ regulatoryT-cells in cerebral ischemic stroke. Metab Brain Dis 2010; 26: 87-90.
38. Rolls A, Shechter R, Schwartz M. The bright side of the glial scar in CNS repair.Nat Rev Neurosci 2009; 10: 235-241.
39. Royl G, Balkaya M, Lehmann S, Lehnardt S, Stohlmann K, Lindauer U et al. Effectsof the PDE5-inhibitor vardenafil in a mouse stroke model. Brain Res 2009; 1265:148-157.